GHK-Cu and wound healing: what the lab research describes
A plain-English read on what lab and animal studies describe for a three-amino-acid copper peptide.
TL;DR
- GHK-Cu is a three-amino-acid peptide bound to copper that occurs naturally in human plasma.
- In lab and animal research, it increased collagen production, helped form new blood vessels, and lowered local inflammation.
- It is not FDA-approved as a wound care drug. Cosmetic versions exist for intact skin.
What it is
GHK-Cu (in plain English: glycyl-histidyl-lysine-copper, a tiny three-amino-acid peptide tied to a single copper atom) is a small molecule the body makes on its own (Pickart et al., BioMed Res Int, 2014). Plasma levels of GHK-Cu drop with age. Researchers describe it as a copper-delivery vehicle that also carries instructions to nearby cells. Think of it as a tiny package — peptide on the outside, copper on the inside — that fibroblasts (in plain English: the skin's repair cells) read like a memo.
How it works
Think of skin healing as a construction site. After an injury, the body needs three crews on site quickly: bricklayers (cells that make collagen and elastin), plumbers (cells that build new blood vessels), and cleanup (immune cells that calm inflammation once the threat is gone). In lab and animal studies, GHK-Cu acted on all three: it signaled fibroblasts to produce more collagen and elastin, supported angiogenesis (in plain English: the formation of new blood vessels into the healing area), and dampened the inflammatory phase (Pickart et al., 2014).
Who asks about it
People come to this topic after a slow-healing scar, a cosmetic procedure recovery, or a serum label that lists GHK-Cu as the headline ingredient. They want to know if the molecule actually does something. The honest answer is that the laboratory and animal work is extensive, and human-skin clinical evidence is small.
What the research says
A 2014 review in BioMed Research International summarized decades of in vitro and animal data in which GHK-Cu accelerated wound contraction, increased collagen deposition, and modulated several genes involved in tissue repair (Pickart et al., 2014). A 2018 review extended the picture to lab and animal studies of tissue repair beyond skin, including bone, liver, and stomach lining (Pickart and Margolina, Int J Mol Sci, 2018). Human randomized trials of GHK-Cu specifically as a wound-healing drug remain limited compared with the mechanism literature.
What to know
GHK-Cu is not FDA-approved as a wound care medication. Cosmetic formulations are sold for intact skin and have light evidence behind appearance-related use. Open wounds, surgical sites, and active dermatologic conditions should be evaluated by a healthcare provider.
The Halftime POV
GHK-Cu is one of the more elegant peptides in the literature. The lab mechanism is well described, and the gap is between mechanism and human outcome data. We will keep reading, and we will not oversell what is still mostly cell and animal work.
Related reading:
- GHK-Cu: the copper peptide and skin biology
- GHK-Cu and collagen: what lab studies describe
- Collagen synthesis: what the peptide literature actually shows
FAQ
Q: What is GHK-Cu? A: GHK-Cu is a three-amino-acid peptide bound to copper. It occurs naturally in human plasma and is studied in skin biology and wound healing research. It is not FDA-approved as a wound care drug.
Q: What does wound-healing research describe for GHK-Cu? A: In laboratory and animal studies, GHK-Cu signaled fibroblasts to produce more collagen and elastin, helped new blood vessels form, and reduced local inflammation. In those models, the matrix around a wound rebuilt faster. Human wound trials are limited.
Q: Can GHK-Cu be used on open wounds? A: GHK-Cu is not FDA-approved as a wound care product, and cosmetic GHK-Cu formulations are marketed for intact skin. An open wound needs care from a healthcare provider.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved.
Sources
Frequently asked questions
What is GHK-Cu?
GHK-Cu is a three-amino-acid peptide bound to copper. It occurs naturally in human plasma and is studied in skin biology and wound healing research. It is not FDA-approved as a wound care drug.
What does wound-healing research describe for GHK-Cu?
In laboratory and animal studies, GHK-Cu signaled fibroblasts to produce more collagen and elastin, helped new blood vessels form, and reduced local inflammation. In those models, the matrix around a wound rebuilt faster. Human wound trials are limited.
Can GHK-Cu be used on open wounds?
GHK-Cu is not FDA-approved as a wound care product, and cosmetic GHK-Cu formulations are marketed for intact skin. An open wound needs care from a healthcare provider.
